{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:10:31Z","timestamp":1754161831520,"version":"3.41.2"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,29]]},"DOI":"10.7759\/cureus.88974","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T12:03:01Z","timestamp":1753790581000},"source":"Crossref","is-referenced-by-count":0,"title":["Synthetic Drug Use and Limitations of Hospital Drug Screening: A Case of Gamma-Hydroxybutyrate Toxicity"],"prefix":"10.7759","author":[{"given":"Lily D","family":"Rundquist","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Newquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erick A","family":"Boldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Pacciulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Echevarria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianna L","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azjaah","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Cherner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.846983","article-title":"Toxicological characterization of GHB as a performance-enhancing drug","volume":"13","author":"Giorgetti A","year":"2022","unstructured":"Giorgetti A, Busard\u00f2 FP, Giorgetti R. Toxicological characterization of GHB as a performance-enhancing drug. Front Psychiatry. 2022, 13:846983. 10.3389\/fpsyt.2022.846983","journal-title":"Front Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0376-8716(00)00191-5","article-title":"GHB: A new and novel drug of abuse","volume":"63","author":"Nicholson KL","year":"2001","unstructured":"Nicholson KL, Balster RL. GHB: A new and novel drug of abuse. Drug Alcohol Depend. 2001, 63:1-22. 10.1016\/s0376-8716(00)00191-5","journal-title":"Drug Alcohol Depend"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2022.2081948","article-title":"Prevalence and correlates of GHB use among adults in the United States","volume":"55","author":"Palamar JJ","year":"2023","unstructured":"Palamar JJ. Prevalence and correlates of GHB use among adults in the United States\r\n. J Psychoactive Drugs. 2023, 55:268-73. 10.1080\/02791072.2022.2081948","journal-title":"J Psychoactive Drugs"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2004.10400040","article-title":"The use of amphetamine in gamma-hydroxybutyrate overdose: a case report","volume":"36","author":"Kohrs FP","year":"2004","unstructured":"Kohrs FP, Mann C, Greenberg R. The use of amphetamine in gamma-hydroxybutyrate overdose: a case report. J Psychoactive Drugs. 2004, 36:401-2. 10.1080\/02791072.2004.10400040","journal-title":"J Psychoactive Drugs"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13049-017-0441-6","article-title":"Intoxication with GHB\/GBL: characteristics and trends from ambulance-attended overdoses","volume":"25","author":"Madah-Amiri D","year":"2017","unstructured":"Madah-Amiri D, Myrmel L, Bratteb\u00f8 G. Intoxication with GHB\/GBL: characteristics and trends from ambulance-attended overdoses. Scand J Trauma Resusc Emerg Med. 2017, 25:98. 10.1186\/s13049-017-0441-6","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2001.112985","article-title":"Gamma-hydroxybutyrate withdrawal syndrome","volume":"37","author":"Dyer JE","year":"2001","unstructured":"Dyer JE, Roth B, Hyma BA. Gamma-hydroxybutyrate withdrawal syndrome. Ann Emerg Med. 2001, 37:147-53. 10.1067\/mem.2001.112985","journal-title":"Ann Emerg Med"},{"key":"ref7","article-title":"G-Hydroxybutyrate (GHB) overdose and withdrawal","author":"Adamo M","year":"2025","unstructured":"Adamo M, Lee S, Lewis J, Kopp Z, Repplinger D. G-Hydroxybutyrate (GHB) overdose and withdrawal. University of California San Francisco (UCSF) Hospital Handbook. The Regents of the University of California, 2025."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7417\/CT.2021.2280","article-title":"Management of GHB acute intoxications","volume":"171","author":"Di Trana A","year":"2021","unstructured":"Di Trana A, Beck R, Del Rio A. Management of GHB acute intoxications. Clin Ter. 2021, 171:e49-51. 10.7417\/CT.2021.2280","journal-title":"Clin Ter"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33695","article-title":"Phenobarbital and alcohol withdrawal syndrome: a systematic review and meta-analysis","volume":"15","author":"Umar Z","year":"2023","unstructured":"Umar Z, Haseeb Ul Rasool M, Muhammad S, et al.. Phenobarbital and alcohol withdrawal syndrome: a systematic review and meta-analysis. Cureus. 2023, 15:e33695. 10.7759\/cureus.33695","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2021.08.012","article-title":"Benzodiazepines and related sedatives","volume":"106","author":"Peng L","year":"2022","unstructured":"Peng L, Morford KL, Levander XA. Benzodiazepines and related sedatives. Med Clin North Am. 2022, 106:113-29. 10.1016\/j.mcna.2021.08.012","journal-title":"Med Clin North Am"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13511","article-title":"Pharmacological treatment for methamphetamine withdrawal: a systematic review and meta-analysis of randomised controlled trials","volume":"42","author":"Acheson LS","year":"2023","unstructured":"Acheson LS, Williams BH, Farrell M, McKetin R, Ezard N, Siefried KJ. Pharmacological treatment for methamphetamine withdrawal: a systematic review and meta-analysis of randomised controlled trials. Drug Alcohol Rev. 2023, 42:7-19. 10.1111\/dar.13511","journal-title":"Drug Alcohol Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.12.007","article-title":"Clinical interpretation of urine drug tests: what clinicians need to know about urine drug screens","volume":"92","author":"Moeller KE","year":"2017","unstructured":"Moeller KE, Kissack JC, Atayee RS, Lee KC. Clinical interpretation of urine drug tests: what clinicians need to know about urine drug screens. Mayo Clin Proc. 2017, 92:774-96. 10.1016\/j.mayocp.2016.12.007","journal-title":"Mayo Clin Proc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2004.10400031","article-title":"Acute toxic effects of club drugs","volume":"36","author":"Gable RS","year":"2004","unstructured":"Gable RS. Acute toxic effects of club drugs. J Psychoactive Drugs. 2004, 36:303-13. 10.1080\/02791072.2004.10400031","journal-title":"J Psychoactive Drugs"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0b013e32833b3397","article-title":"Behavioral effects of gamma-hydroxybutyrate in humans","volume":"21","author":"Oliveto A","year":"2010","unstructured":"Oliveto A, Gentry WB, Pruzinsky R, Gonsai K, Kosten TR, Martell B, Poling J. Behavioral effects of gamma-hydroxybutyrate in humans. Behav Pharmacol. 2010, 21:332-42. 10.1097\/FBP.0b013e32833b3397","journal-title":"Behav Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0028-3908(99)00131-8","article-title":"Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors","volume":"38","author":"Lingenhoehl K","year":"1999","unstructured":"Lingenhoehl K, Brom R, Heid J, et al.. Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors. Neuropharmacology. 1999, 38:1667-73. 10.1016\/s0028-3908(99)00131-8","journal-title":"Neuropharmacology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-020-00543-z","article-title":"\u03b3-Hydroxybutyric acid: pharmacokinetics, pharmacodynamics, and toxicology","volume":"23","author":"Felmlee MA","year":"2021","unstructured":"Felmlee MA, Morse BL, Morris ME. \u03b3-Hydroxybutyric acid: pharmacokinetics, pharmacodynamics, and toxicology. AAPS J. 2021, 23:22. 10.1208\/s12248-020-00543-z","journal-title":"AAPS J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s40429-023-00531-1","article-title":"Pharmacological treatment of GHB withdrawal syndrome","volume":"11","author":"Karila L","year":"2024","unstructured":"Karila L, Angerville B, Benyamina A, Billieux J. Pharmacological treatment of GHB withdrawal syndrome. Curr Addict Rep. 2024, 11:163-71. 10.1007\/s40429-023-00531-1","journal-title":"Curr Addict Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/376055-synthetic-drug-use-and-limitations-of-hospital-drug-screening-a-case-of-gamma-hydroxybutyrate-toxicity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T12:03:01Z","timestamp":1753790581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/376055-synthetic-drug-use-and-limitations-of-hospital-drug-screening-a-case-of-gamma-hydroxybutyrate-toxicity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.88974","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,29]]}}}